Kenya Transport Strike Over Fuel Prices Disrupts Commutes and Business Activity Gas Prices Surge to 452 Amid WarDriven Inflation Trump Calls for Federal Fuel Tax Suspension PrimeEnergy PNRG Q4 2025 Earnings Revenue NA Matching Views US Importers Walmart and Target Poised for Billions in Tariff Refunds as Government Portal Opens Next Week Arrowhead Pharmaceuticals Presents Plozasiran Data on Renal and Hepatic Impairment SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags The AI Stock Landscape Shifting Analyst Focus Beyond the Usual Suspects Waterfield Advisors Sees Peak Macro Concerns Behind Advocates Staggered Accumulation Strategy Foreign Investors Rotate from Nifty Giants to Indias Small and Midcap Markets Amid Growth Opportunities Jay Thakkar Recommends Three FO Stocks for ShortTerm as Nifty Faces Resistance at 24100 SRTS Q1 2026 Earnings EPS Miss Amid Revenue Uncertainty Stock Gains 16 ARBK Q2 2024 Earnings Bitcoin Mining Headwinds Persist as EPS Misses Amid Unreported Revenue VBNK Q1 2026 Earnings EPS Misses Estimates as Earnings Fall Short APTV Q1 2026 Earnings EPS Surges Past Estimates as Operational Discipline Drives Beat THCH Q4 2025 Earnings Reported Loss Per Share of 23174 Stock Gains 285 Amid Lack of Revenue Detail IO Biotech Q3 2025 Earnings EPS Beats Estimates by 6067 as Narrowing Losses Highlight Cost Discipline Atara Biotherapeutics ATRA Faces Selling Pressure Near Key Resistance Zone BlackRock MultiSector Income Trust BIT Edges Higher as IncomeSeeking Investors Rotate into FixedIncome CEFs Jyong Biotech Ltd MENS Surges 337 as Buyers Defend Key Support Level Lineage Cell Therapeutics LCTX Holds Near Support as Biotech Sector Headwinds Persist Redwood Trust 2030 Notes RWTQ Holds Steady Near Key Resistance Levels General Purpose Acquisition Corp Units GPACU Holds Steady at 1009 as SPAC Unit Nears Key Resistance Gold Under Pressure as Feds Waller Flags Potential Rate Hike Amid Iran War Energy Shock RKLB Q1 2026 Earnings EPS Beats Estimates as Rocket Lab Narrows Losses Ovid Therapeutics Gains Momentum Eyes Critical Resistance at 277